Conclusions by Peter Openshaw, Co-Chair of the the ESWI Respiratory Virus Summit 2024

How to ensure/prepare for access to immunisation programmes

By Ab Osterhaus, Host of the ESWI Respiratory Virus Summit 2024

Live attenuated vaccines; NIRSE-GAL: Evaluation of the effectiveness and impact of Nirsevimab in Galicia; and Therapeutics

ESWI Summit 2024: Early Career Scientists They each delivered a presentation introducing themselves and their ongoing work on RSV, bringing innovative ideas and making clear calls for action.

Keynote Lecture by Dexter Wiseman, Imperial College London

Keynote Lecture by Stefan Gravenstein, Brown University

Keynote Lecture by Simon Drysdale, St George's University Hospitals NHS Foundation Trust

The European Commission has launched a call for expression of interest aiming at the selection of the ECDC Advisory Forum members. The deadline for submission of applications is 4 April 2024.

People living in the United States are more likely to report that their government handled the COVID-19 pandemic ‘well’ than any other G7 nation despite having the highest death rate, according to a new report from the Global Listening Project.

Nearly 20 million people aged 60 years and above received COVID-19 vaccines during the autumn/winter campaign in the EU/EEA, according to a new report from the European Centre for Disease Prevention and Control (ECDC).

During the COVID-19 pandemic, levels of seasonal influenza virus circulation were unprecedentedly low, leading to concerns that a lack of exposure to influenza viruses, combined with waning antibody titres.